Literature DB >> 8052619

A human oncogene of the RAS superfamily unmasked by expression cDNA cloning.

A M Chan1, T Miki, K A Meyers, S A Aaronson.   

Abstract

As an approach to identify human oncogenes, we generated an expression cDNA library from an ovarian carcinoma line. A potent transforming gene was detected by transfection analysis and identified as TC21, a recently cloned member of the RAS gene superfamily. A single point mutation substituting glutamine for leucine at position 72 was shown to be responsible for activation of transforming properties. While the cDNA clone possessed high transforming activity, the ovarian tumor genomic DNA, which contained the mutated TC21 allele, failed to induce transformed foci. Thus, expression cDNA cloning made it possible to identify and isolate a human oncogene that has evaded detection by conventional approaches.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8052619      PMCID: PMC44441          DOI: 10.1073/pnas.91.16.7558

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Structure of the human and murine R-ras genes, novel genes closely related to ras proto-oncogenes.

Authors:  D G Lowe; D J Capon; E Delwart; A Y Sakaguchi; S L Naylor; D V Goeddel
Journal:  Cell       Date:  1987-01-16       Impact factor: 41.582

2.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

3.  Characterization and developmental expression of a Drosophila ras oncogene.

Authors:  B Mozer; R Marlor; S Parkhurst; V Corces
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

Review 4.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Mammalian Ras interacts directly with the serine/threonine kinase Raf.

Authors:  A B Vojtek; S M Hollenberg; J A Cooper
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

6.  Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.

Authors:  Y Yuasa; S K Srivastava; C Y Dunn; J S Rhim; E P Reddy; S A Aaronson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

7.  Heterologous expression and characterization of the human R-ras gene product.

Authors:  D G Lowe; D V Goeddel
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

8.  The Drosophila ras oncogenes: structure and nucleotide sequence.

Authors:  F S Neuman-Silberberg; E Schejter; F M Hoffmann; B Z Shilo
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

9.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells.

Authors:  P P Di Fiore; J H Pierce; T P Fleming; R Hazan; A Ullrich; C R King; J Schlessinger; S A Aaronson
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

10.  Expression of an activated ras gene causes developmental abnormalities in transgenic Drosophila melanogaster.

Authors:  J G Bishop; V G Corces
Journal:  Genes Dev       Date:  1988-05       Impact factor: 11.361

View more
  31 in total

1.  Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate.

Authors:  Pablo Rodriguez-Viciana; Celine Sabatier; Frank McCormick
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

2.  Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.

Authors:  Tetsuya Niihori; Koki Nagai; Atsushi Fujita; Hirofumi Ohashi; Nobuhiko Okamoto; Satoshi Okada; Atsuko Harada; Hirotaka Kihara; Thomas Arbogast; Ryo Funayama; Matsuyuki Shirota; Keiko Nakayama; Taiki Abe; Shin-Ichi Inoue; I-Chun Tsai; Naomichi Matsumoto; Erica E Davis; Nicholas Katsanis; Yoko Aoki
Journal:  Am J Hum Genet       Date:  2019-05-23       Impact factor: 11.025

3.  Differential roles of Akt, Rac, and Ral in R-Ras-mediated cellular transformation, adhesion, and survival.

Authors:  M Osada; T Tolkacheva; W Li; T O Chan; P N Tsichlis; R Saez; A C Kimmelman; A M Chan
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Essential function for the GTPase TC21 in homeostatic antigen receptor signaling.

Authors:  Pilar Delgado; Beatriz Cubelos; Enrique Calleja; Nuria Martínez-Martín; Angel Ciprés; Isabel Mérida; Carmen Bellas; Xosé R Bustelo; Balbino Alarcón
Journal:  Nat Immunol       Date:  2009-06-28       Impact factor: 25.606

5.  TC21 causes transformation by Raf-independent signaling pathways.

Authors:  S M Graham; A B Vojtek; S Y Huff; A D Cox; G J Clark; J A Cooper; C J Der
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

6.  Characterization of R-ras3/m-ras null mice reveals a potential role in trophic factor signaling.

Authors:  Nelson Nuñez Rodriguez; Ivy N L Lee; Asoka Banno; Hui F Qiao; Rui F Qiao; Zhong Yao; Thuong Hoang; Alec C Kimmelman; Andrew M-L Chan
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

7.  R-Ras1 and R-Ras2 Are Essential for Oligodendrocyte Differentiation and Survival for Correct Myelination in the Central Nervous System.

Authors:  Miriam Sanz-Rodriguez; Agnès Gruart; Juan Escudero-Ramirez; Fernando de Castro; José María Delgado-García; Francisco Wandosell; Beatriz Cubelos
Journal:  J Neurosci       Date:  2018-05-02       Impact factor: 6.167

8.  Structural and spatial determinants regulating TC21 activation by RasGRF family nucleotide exchange factors.

Authors:  Fernando Calvo; Piero Crespo
Journal:  Mol Biol Cell       Date:  2009-08-19       Impact factor: 4.138

9.  Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells.

Authors:  Yuan Huang; Fatima Rangwala; Patricia C Fulkerson; Bo Ling; Erin Reed; Adrienne D Cox; John Kamholz; Nancy Ratner
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

10.  In vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1.

Authors:  Deanna M Patmore; Sara Welch; Patricia C Fulkerson; Jianqiang Wu; Kwangmin Choi; David Eaves; Jennifer J Kordich; Margaret H Collins; Timothy P Cripe; Nancy Ratner
Journal:  Cancer Res       Date:  2012-08-23       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.